Drug Repurposing and Dosage Form Development of Anti-COVID-19
The COVID-19 pandemic has been occurring approximately for more than 1 year. This pandemic has been a health issue that hits all countries in the world caused by the transmission of SARS-CoV-2 virus from one individual to another. The symptoms showed from the infected are fever, shortness of breath,...
Saved in:
Main Author: | Kevin Kwok (Author) |
---|---|
Format: | Book |
Published: |
Universitas Indonesia,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020) -
Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
by: Fatih M. Uckun, et al.
Published: (2021) -
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
by: Vivek P. Chavda, et al.
Published: (2021) -
Drug repurposing for the treatment of COVID-19
by: Yuri Kato, et al.
Published: (2022) -
Multi-Methodological Quantitative Taste Assessment of Anti-Tuberculosis Drugs to Support the Development of Palatable Paediatric Dosage Forms
by: Alison V. Keating, et al.
Published: (2020)